The current evaluation and treatment of infantile spasms among members of the Child Neurology Society.
The optimal evaluation and treatment of children with infantile spasms is unknown. To aid in the development of a standardized approach to infantile spasms, members of the Child Neurology Society were surveyed to determine common practice. The survey had 222 responders with a responder rate of 18.5%. We found that the diagnostic evaluation and the use of first-line treatments varied among responders. For example, although adrenocorticotropic hormone continues to be the most commonly used first-line treatment for infantile spasms not due to tuberous sclerosis, some clinicians use corticosteroids, vigabatrin, and topiramate as first-line treatments for this group. Seventy percent of our responders reported seeing fewer than 10 new-onset cases of infantile spasms per year. Thus, future clinical trials will require multicenter collaboration. An important first step in such collaboration is to standardize the evaluation and treatment of infantile spasms within and between participating centers.
Department of Neurology, University of Virginia Health System, Charlottesville, VA, USA.
John R
JR
Mytinger
Sucheta
S
Joshi
D000324:Adrenocorticotropic Hormone / Q000627:therapeutic use*; D002675:Child, Preschool; D006306:Health Surveys; D006801:Humans; D007223:Infant; D009462:Neurology; D017063:Outcome Assessment, Health Care / Q000379:methods* / Q000592:standards*; D010372:Pediatrics; D012955:Societies, Medical / Q000592:standards; D013036:Spasms, Infantile / Q000175:diagnosis / Q000188:drug therapy*
D000324:Adrenocorticotropic Hormone